Vignesh Ramachandran, MD
About Vignesh Ramachandran, MD
Vignesh Ramachandran, MD, is a Clinical Product Validator and Clinical Trial Investigator with extensive experience in dermatology and healthcare innovation.
Professional Title and Roles
Vignesh Ramachandran, MD, currently holds multiple roles including Clinical Product Validator & Clinical Trial Investigator. He serves as Clinical and Strategic Advisor at FlexTogether and is a Healthcare Finance Committee Member for the American Academy of Dermatology. Additionally, he is a Senior Dermatology Resident Physician at New York University and works at NYU Langone Health and Ahammune Biosciences Pvt. Ltd. in various capacities.
Professional Experience
Vignesh Ramachandran has amassed significant experience in the medical and healthcare fields. He worked as a Medical Consultant at Ambience Healthcare and served as an Innovation Fellow for the Virtual Magic Wand Program at Harvard Medical School and Massachusetts General Hospital. Prior to these roles, he was a Resident Physician at Texas Health Resources and engaged in Clinical Product Validation and Clinical Trial Investigations with the United States Department of Defense.
Educational Background
Vignesh Ramachandran completed his Dermatology Residency at New York University. He earned his Doctor of Medicine (M.D.) from Baylor College of Medicine and a Bachelor of Science (B.S.) in Biology (Honors) from The University of Texas at Austin. His extensive training forms a solid foundation for his current roles and research interests.
Research Contributions
Vignesh Ramachandran has a significant research profile, with over 90 peer-reviewed publications available on ResearchGate. His research interests focus heavily on procedural dermatology, particularly excisions, lasers, and neurotoxin injections. His contributions to the field are well-documented and widely respected.
Clinical Interests and Missions
Vignesh Ramachandran is deeply interested in procedural dermatology. His clinical practice includes excisions, laser treatments, and neurotoxin injections. Beyond his clinical duties, he contributes to strategic initiatives and provides clinical insights for a virtual pulmonary rehabilitation startup partnered with Cedars-Sinai Accelerator. He aims to blend medicine and finance to serve marginalized communities through service and philanthropy.